You searched for "regenerative"

1391 results found

Blindness from some inherited eye diseases may be caused by gut bacteria

Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.

In conversation with Vasuki Sivagnanavel at 100% Optical

At 100% Optical at the end of February, we were lucky enough to run into Vasuki Sivagnanavel, Consultant Ophthalmic Surgeon at The Royal Eye Unit, Kingston Hospital, shortly after her presentation: 'Diagnostic insights with retinal ultra-widefield multimodal imaging - perspectives from an optometrist and ophthalmologist'.

Free rail travel for blind and partially sighted people and their companions announced for Scotland

Leading sight loss charities have hailed the Scottish Government’s ‘life changing’ decision to provide free rail travel for blind and partially sighted people and their companions, saying this decision will enhance rehabilitation, independence and ensuring people with vision impairment can maintain links with their communities.

Eye surgeon behind destroyed Gaza hospital is honoured with a special recognition award

A Manchester-based eye surgeon who has made it his life’s mission to provide internationally-renowned eye care for the people of occupied Gaza, West Bank and East Jerusalem, has received a Health Champion Award from The Tropical Health & Education Trust (THET) at a special ceremony in London.

Mayor opens new community eye clinic for Lancashire

To further support eye-health for people in the Lancashire region, a new permanent eye care facility has opened in the heart of Bamber Bridge, just three miles from Preston. Opened yesterday by the Mayor and Mayoress of South Ribble Borough...

Glaucoma and cataract CPD sessions for optometrists and dispensing opticians at 100% Optical

The importance of ophthalmology and optometry working together to transform care for patients with conditions such as cataracts and glaucoma will come under the spotlight at 100% Optical. NHS ophthalmology provider Newmedica is hosting a series of continuing professional development...

Conference Report: The Medical Ophthalmology Society UK (MOSUK) 26th Annual Meeting

The Medical Ophthalmology Society UK (MOSUK) held its 26th annual meeting on 26 February 2025 at the International Students House in Great Portland Street, London. Medical ophthalmology is a distinctive and holistic speciality that encompasses the investigation, diagnosis, and management...

Cornea, 2-Volume Set: Fundamentals, Diagnosis, Management and Surgery of the Cornea and Conjunctiva (4th Edition)

Originally published in 1997 as a comprehensive set of three volumes on cornea and external eye disease, this two volume edition, published at the end of 2016, offers “a complete multimedia resource, in print, online, eBook and video format”. There...

Essentials of OCT in Ocular Disease

Sir Isaac Newton was the first to establish the technique of low coherence white light interferometry. Following on from this, the principle of laser interferometry as an imaging modality for retina was applied by David Huang and his associates in...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

Safety and efficacy of a nurse-led intravitreal injection service using an Precivia® injection assist device

Nurse-led intravitreal injections have become of great importance for busy eye units. In this article, the authors present safety data from five years of a nurse-led service with the use of the Precivia® intravitreal injection assist device. Intravitreal injections of...

Licence to save: a UK survey of anti-VEGF use for the eye

This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...